Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2

Status

Unknown 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 12Gynecologic 4Sarcoma 2Thoracic 1Lymphoid 1

Conditions

Endometrial Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Gynecologic Cancer 1

Interventions

Paclitaxel 575Carboplatin 521Cisplatin 351Bevacizumab 252pembrolizumab 228Gemcitabine 157Topotecan 128Cyclophosphamide 128liposomal doxorubicin 127olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 81niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 57Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Enhanced Recovery After Surgery × Gynecologic × Clear all
NCT06732635 2024-12-13

FAST-TRACK

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Phase 3 Completed
68 enrolled
Gynecologic

Endometrial Neoplasms

NCT04596800 2023-10-31

PROPER

Instituto Brasileiro de Controle do Cancer

Phase 3 Unknown
194 enrolled
Gynecologic

Gynecologic Cancer

NCT04063072 2021-06-02

ERAS-Gyneco

Ospedale Regina Montis Regalis

Phase NA Unknown
1,800 enrolled
Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT02172638 2019-09-30

PROFAST

Hospital Universitari Vall d'Hebron Research Institute

Phase NA Completed
110 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡